As of January 23, 2025, Carisma Therapeutics (CARM) has a market cap of $18.378 million USD. According to our data, Carisma Therapeutics is ranked No.8642 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $18.38 M |
5.06%
|
Dec 31, 2024 | $17.49 M |
-85.70%
|
Dec 29, 2023 | $0.12 B |
-75.27%
|
Dec 30, 2022 | $0.49 B |
-25.15%
|
Dec 31, 2021 | $0.66 B |
-39.63%
|
Dec 31, 2020 | $1.09 B |
29.81%
|
Dec 31, 2019 | $0.84 B |
-26.76%
|
Dec 31, 2018 | $1.15 B |
75.09%
|
Dec 29, 2017 | $0.66 B |
-57.54%
|
Dec 30, 2016 | $1.55 B |
-36.54%
|
Dec 31, 2015 | $2.44 B |
-74.66%
|
Dec 31, 2014 | $9.64 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Market Cap | = | CARM Stock Price | * | CARM Shares Outstanding |
= | $0.44 | * | 41.75 M | |
= | $18.38 M |